Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT00159003Completed

Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel

Role: lead

NCT00159068Completed

Analysis of Genetic Factors Which May Influence the Course of HIV Infection

Role: lead

NCT00159029Completed

Genetics of Alpha Thalassemia in Israeli Ethnic Groups

Role: lead

NCT00159042Completed

Genetic Factors Affecting the Severity of Beta Thalassemia

Role: lead

All 4 trials loaded